These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12824534)

  • 1. Analysis of nuclear and cytoplasmic degradation of p53 in cells after stress.
    Joseph TW; Moll UM
    Methods Mol Biol; 2003; 234():211-7. PubMed ID: 12824534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage.
    Joseph TW; Zaika A; Moll UM
    FASEB J; 2003 Sep; 17(12):1622-30. PubMed ID: 12958168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53.
    Xirodimas DP; Stephen CW; Lane DP
    Exp Cell Res; 2001 Oct; 270(1):66-77. PubMed ID: 11597128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear degradation of p53 occurs during down-regulation of the p53 response after DNA damage.
    Shirangi TR; Zaika A; Moll UM
    FASEB J; 2002 Mar; 16(3):420-2. PubMed ID: 11790725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoubiquitination: the signal for p53 nuclear export?
    Brooks CL; Li M; Gu W
    Cell Cycle; 2004 Apr; 3(4):436-8. PubMed ID: 14976431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of p53 by Mdm2: fate is in the numbers.
    Shmueli A; Oren M
    Mol Cell; 2004 Jan; 13(1):4-5. PubMed ID: 14731389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular biology. Getting p53 out of the nucleus.
    Gottifredi V; Prives C
    Science; 2001 Jun; 292(5523):1851-2. PubMed ID: 11397937
    [No Abstract]   [Full Text] [Related]  

  • 8. The MDM2-p53 interaction.
    Moll UM; Petrenko O
    Mol Cancer Res; 2003 Dec; 1(14):1001-8. PubMed ID: 14707283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53.
    Tao W; Levine AJ
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3077-80. PubMed ID: 10077639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein.
    Roth J; Dobbelstein M; Freedman DA; Shenk T; Levine AJ
    EMBO J; 1998 Jan; 17(2):554-64. PubMed ID: 9430646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6.
    Freedman DA; Levine AJ
    Mol Cell Biol; 1998 Dec; 18(12):7288-93. PubMed ID: 9819415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmically "sequestered" wild type p53 protein is resistant to Mdm2-mediated degradation.
    Zaika A; Marchenko N; Moll UM
    J Biol Chem; 1999 Sep; 274(39):27474-80. PubMed ID: 10488081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-terminal ubiquitination of p53 contributes to nuclear export.
    Lohrum MA; Woods DB; Ludwig RL; Bálint E; Vousden KH
    Mol Cell Biol; 2001 Dec; 21(24):8521-32. PubMed ID: 11713287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway.
    Brignone C; Bradley KE; Kisselev AF; Grossman SR
    Oncogene; 2004 May; 23(23):4121-9. PubMed ID: 15064742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p14ARF induces the relocation of HDM2 and p53 to extranucleolar sites that are targeted by PML bodies and proteasomes.
    Kashuba E; Mattsson K; Klein G; Szekely L
    Mol Cancer; 2003 Mar; 2():18. PubMed ID: 12685933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53.
    Boyd SD; Tsai KY; Jacks T
    Nat Cell Biol; 2000 Sep; 2(9):563-8. PubMed ID: 10980695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear exclusion of p53 in a subset of tumors requires MDM2 function.
    Lu W; Pochampally R; Chen L; Traidej M; Wang Y; Chen J
    Oncogene; 2000 Jan; 19(2):232-40. PubMed ID: 10645001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDM2 can promote the ubiquitination, nuclear export, and degradation of p53 in the absence of direct binding.
    Inoue T; Geyer RK; Howard D; Yu ZK; Maki CG
    J Biol Chem; 2001 Nov; 276(48):45255-60. PubMed ID: 11572869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MDM2 RING-finger domain is required to promote p53 nuclear export.
    Geyer RK; Yu ZK; Maki CG
    Nat Cell Biol; 2000 Sep; 2(9):569-73. PubMed ID: 10980696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway.
    Chang YC; Lee YS; Tejima T; Tanaka K; Omura S; Heintz NH; Mitsui Y; Magae J
    Cell Growth Differ; 1998 Jan; 9(1):79-84. PubMed ID: 9438391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.